For the quarter ending 2025-09-30, JYNT had -$286,220 decrease in cash & cash equivalents over the period. $1,455,192 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net income (loss) | 855,009 | 93,363 | 967,796 | -5,796,893 |
| Depreciation and amortization | 463,046 | 419,414 | 388,316 | 4,722,137 |
| Net loss on disposition or impairment (non-cash portion) | -860,597 | -1,756,935 | -1,135,330 | -7,780,574 |
| Net franchise fees recognized upon termination of franchise agreements | 83,512 | 74,167 | 100,118 | 239,335 |
| Deferred income taxes | 0 | 0 | 0 | -55,556 |
| Provision for credit losses | 149,719 | - | - | 220,893 |
| Stock-based compensation expense | 346,209 | 330,988 | 293,941 | 1,679,005 |
| Accounts receivable | 94,157 | -95,629 | -1,462,554 | 1,645,078 |
| Prepaid expenses and other current assets | -1,319,084 | -273,445 | 2,017,426 | -101,167 |
| Deferred franchise costs | -199,147 | -9,975 | -173,864 | -499,285 |
| Deposits and other assets | 37,612 | -2,418 | -15,914 | -8,827 |
| Assets and liabilities held for sale, net | 0 | 0 | 0 | - |
| Accounts payable | -558,828 | 390,479 | -481,554 | 68,258 |
| Accrued expenses | -67,300 | -419,496 | -2,989,008 | 4,609,759 |
| Payroll liabilities | 521,158 | -371,037 | -1,075,561 | 2,398,765 |
| Operating leases | -1,124,332 | -1,440,987 | -1,278,637 | -3,796,648 |
| Deferred revenue | -1,135,131 | -263,436 | -245,129 | -597,489 |
| Upfront regional developer fees | -69,919 | -72,375 | -73,230 | -421,213 |
| Other liabilities | 229,854 | 137,501 | 122,294 | -121,408 |
| Net cash (used in) provided by operating activities | 1,773,032 | 868,649 | -3,700,654 | 9,415,050 |
| Proceeds from sale of clinics | 0 | 7,738,187 | 40,100 | 554,100 |
| Purchase of property and equipment | 317,840 | 505,040 | 331,505 | 1,185,647 |
| Acquisition of ca clinics | - | - | - | 0 |
| Net cash provided by (used in) investing activities | -317,840 | 7,233,147 | -291,405 | -631,547 |
| Payments of finance lease obligation | 0 | 0 | 4,354 | 25,484 |
| Purchases of treasury stock under employee stock plans | 8,440 | - | - | - |
| Purchases of treasury stock under employee stock plans | 2,280,554 | 0 | 8,440 | 9,583 |
| Proceeds from exercise of stock options | 547,582 | 0 | 905,976 | 33,708 |
| Repayment of debt under the credit agreement | 0 | 0 | 0 | 2,000,000 |
| Net cash used in financing activities | -1,741,412 | 0 | 893,182 | -2,001,359 |
| Increase in cash, cash equivalents and restricted cash | -286,220 | 8,101,796 | -3,098,877 | 6,782,144 |
| Cash and cash equivalents at beginning of period | 25,996,436 | - | - | - |
| Cash and cash equivalents at end of period | 30,713,135 | - | - | - |
JOINT Corp (JYNT)
JOINT Corp (JYNT)